By Matthew Perlman ( October 5, 2016, 6:45 PM EDT) -- Teva Pharmaceutical Industries Ltd. said Wednesday that it has agreed to sell some of Allergan's assets in the U.K. and Ireland to Intas Pharmaceuticals Ltd. in a deal worth £603 million ($768.7 million), fulfilling part of the antitrust obligations for its takeover of Allergan's generics business....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.